Levamisole and interferon in children with chronic hepatitis B
Mercedes Ruiz‐Moreno, Rosa García, Maria Jose Rua, Beatriz Serrano, Gloria Moraleda, Esperanza Feijoo, Javier Bartolomé, Fernando Ortiz, Inmaculada Castill, Vicente Carreñ – 1 August 1993 – To evaluate the possible usefulness of simultaneous administration of levamisole and interferon, we randomly allocated 38 children with chronic hepatitis B to receive either 10 MU/m2 interferon‐α‐2a, three times a week for 6 mo (group 1, n = 20) or 90 mg/m2 of levamisole for 45 days, together with 10 MU/m2 of interferon‐α‐2a, three times a week for 6 mo (group 2, n = 18).